A detailed history of Uss Investment Management LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Uss Investment Management LTD holds 19,642 shares of REGN stock, worth $14.1 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
19,642
Previous 19,924 1.42%
Holding current value
$14.1 Million
Previous $20.9 Million 1.39%
% of portfolio
0.16%
Previous 0.17%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1024.09 - $1201.76 $288,793 - $338,896
-282 Reduced 1.42%
19,642 $20.6 Million
Q2 2024

Aug 13, 2024

BUY
$883.2 - $1071.19 $351,513 - $426,333
398 Added 2.04%
19,924 $20.9 Million
Q1 2024

May 15, 2024

BUY
$902.69 - $993.35 $362,881 - $399,326
402 Added 2.1%
19,526 $18.8 Million
Q4 2023

Feb 14, 2024

SELL
$775.18 - $881.7 $689,135 - $783,831
-889 Reduced 4.44%
19,124 $16.8 Million
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $593,429 - $723,625
857 Added 4.47%
20,013 $16.5 Million
Q2 2023

Aug 14, 2023

BUY
$700.03 - $830.35 $177,107 - $210,078
253 Added 1.34%
19,156 $13.8 Million
Q1 2023

May 12, 2023

BUY
$680.49 - $826.97 $229,325 - $278,688
337 Added 1.82%
18,903 $15.5 Million
Q4 2022

Feb 13, 2023

BUY
$705.89 - $766.39 $252,708 - $274,367
358 Added 1.97%
18,566 $13.4 Million
Q3 2022

Nov 08, 2022

SELL
$573.97 - $724.32 $3.07 Million - $3.87 Million
-5,344 Reduced 22.69%
18,208 $12.6 Million
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $864,747 - $1.17 Million
-1,577 Reduced 6.28%
23,552 $13.9 Million
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $521,920 - $612,523
877 Added 3.62%
25,129 $17.6 Million
Q3 2021

Nov 15, 2021

BUY
$574.03 - $680.96 $10.4 Million - $12.4 Million
18,204 Added 300.99%
24,252 $14.7 Million
Q4 2020

Feb 12, 2021

SELL
$478.3 - $607.98 $334,810 - $425,586
-700 Reduced 10.37%
6,048 $2.92 Million
Q2 2020

Aug 11, 2020

BUY
$493.32 - $643.92 $3.33 Million - $4.35 Million
6,748 New
6,748 $4.21 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Uss Investment Management LTD Portfolio

Follow Uss Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.